Synergistic antibacterial and anti-inflammatory activity of temporin A and modified temporin B in vivo

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Capparelli, Rosanna ^a   Romanelli, Alessandra ^a   Iannaccone, Marco ^a   Nocerino, Nunzia ^a   Ripa, Raffaella ^a   Pensato, Soccorsa ^a   Pedone, Carlo ^a   Iannelli, Domenico ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; TEMPORIN A; TEMPORIN B DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; PEPTIDE; PROTEIN; TEMPORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VIVO STUDY; LETHAL DOSE; MOUSE; NONHUMAN; STAPHYLOCOCCUS INFECTION; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; CIRCULAR DICHROISM; ESCHERICHIA COLI; FROG; LISTERIA MONOCYTOGENES; METABOLISM; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS;

ANIMALIA; ANURA; BACTERIA (MICROORGANISMS); MUS; NEGIBACTERIA; POSIBACTERIA; RANA TEMPORARIA;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CIRCULAR DICHROISM; ESCHERICHIA COLI; FEMALE; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED BALB C; PEPTIDES; PROTEINS; RANA TEMPORARIA; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS;

EID: 70349690160     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007191     Document Type: Article

References (32)

1. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
2. Boman HG (2003) Antibacterial peptides: basic facts and emerging concepts. J Intern Med 254: 197-215.
3. Levy SB, Marshall B (2004) Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10: S122-129.
4. Papagianni M (2003) Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications. Biotechnol Adv 21: 465-499.
5. Hancock RE (2001) Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1: 156-164.
6. Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, et al. (1996) Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur J Biochem 242: 788-792.
7. Lu Y, Li J, Yu H, Xu X, Liang J, et al. (2006) Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis. Peptides 27: 3085-3091.
8. Bradbury AF, Smyth DG (1991) Peptide amidation. Trends Biochem Sci 16: 112-115.
9. Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, Orlando F, et al. (2006) Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. Antimicrob Agents Chemother 50: 2478-2486.
10. Rosenfeld Y, Barra D, Simmaco M, Shai Y, Mangoni ML (2006) A synergism between temporins toward Gram-negative bacteria overcomes resistance imposed by the lipopolysaccharide protective layer. J Biol Chem 281: 28565-28574.
11. Shai Y (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1462: 55-70.
12. Shai Y (2002) Mode of action of membrane active antimicrobial peptides. Biopolymers 66: 236-248.
13. Rathinakumar R, Walkenhorst WF, Wimley WC (2009) Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. J Am Chem Soc 131: 7609-7617.
14. Conlon JM, Al-Ghaferi N, Abraham B, Leprince J (2007) Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Methods 42: 349-357.
15. Carotenuto A, Malfi S, Saviello MR, Campiglia P, Gomez-Monterrey I, et al. (2008) A different molecular mechanism underlying antimicrobial and hemolytic actions of temporins A and L. J Med Chem 51: 2354-2362.
16. Hujakka H, Ratilainen J, Korjamo T, Lankinen H, Kuusela P, et al. (2001) Synthesis and antimicrobial activity of the symmetric dimeric form of Temporin A based on 3-N,N-di(3-aminopropyl)amino propanoic acid as the branching unit. Bioorg Med Chem 9: 1601-1607.
17. Oh H, Hedberg M, Wade D, Edlund C (2000) Activities of synthetic hybrid peptides against anaerobic bacteria: aspects of methodology and stability. Antimicrob Agents Chemother 44: 68-72.
18. Cirioni O, Giacometti A, Ghiselli R, Kamysz W, Orlando F, et al. (2005) Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. J Infect Dis 192: 1613-1620.
19. Edman P (1950) Method for determination of the amino acid sequence in peptides. Acta Chemica Scandinavica. 283-293.
20. Becker K, Roth R, Peters G (1998) Rapid and specific detection of toxigenic Staphylococcus aureus: use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J Clin Microbiol 36: 2548-2553.
21. Bubert A, Hein I, Rauch M, Lehner A, Yoon B, et al. (1999) Detection and differentiation of Listeria spp. by a single reaction based on multiplex PCR. Appl Environ Microbiol 65: 4688-4692.
22. Hong Y, Liu T, Lee MD, Hofacre CL, Maier M, et al. (2008) Rapid screening of Salmonella enterica serovars Enteritidis, Hadar, Heidelberg and Typhimurium using a serologically-correlative allelotyping PCR targeting the O and H antigen alleles. BMC Microbiol 8: 178.
23. Ananias M, Yano T (2008) Serogroups and virulence genotypes of Escherichia coli isolated from patients with sepsis. Braz J Med Biol Res 41: 877-883.
24. Cormack BP, Bertram G, Egerton M, Gow NA, Falkow S, et al. (1997) Yeast-enhanced green fluorescent protein (yEGFP) a reporter of gene expression in Candida albicans. Microbiology 143 (Pt 2): 303-311.
25. Lee J, Choi Y, Woo ER, Lee DG (2009) Isocryptomerin, a novel membrane-active antifungal compound from Selaginella tamariscina. Biochem Biophys Res Commun 379: 676-680.
26. Zhao H, Rinaldi AC, Di Giulio A, Simmaco M, Kinnunen PK (2002) Interactions of the antimicrobial peptides temporins with model biomembranes. Comparison of temporins B and L. Biochemistry 41: 4425-4436.
27. Rinaldi AC, Mangoni ML, Rufo A, Luzi C, Barra D, et al. (2002) Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles. Biochem J 368: 91-100.
28. Mangoni ML, Rinaldi AC, Di Giulio A, Mignogna G, Bozzi A, et al. (2000) Structure-function relationships of temporins, small antimicrobial peptides from amphibian skin. Eur J Biochem 267: 1447-1454.
29. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG (2006) Statins: panacea for sepsis? Lancet Infect Dis 6: 242-248.
30. Feezor RJ, Oberholzer C, Baker HV, Novick D, Rubinstein M, et al. (2003) Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun 71: 5803-5813.
31. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, et al. (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101: 311-320.
32. Buras JA, Holzmann B, Sitkovsky M (2005) Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4: 854-865.